Special Issue "Radiation Therapy in Thoracic Tumors: Recent Trends and Current Issues"
Deadline for manuscript submissions: 31 January 2022.
Interests: radiation oncology physics; radiation therapy optimization; radiation-induced side effects; clinical radiobiology; machine learning; voxel-based analysis
Interests: radiation therapy; magnetic resonance imaging; image analysis; algorithms; modeling
2. Ontario and Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada
Interests: radiation-induced normal tissue toxicity; predictive modeling; machine learning
Over the past several years, radiation therapy for thoracic tumors and its treatment planning have significantly progressed. Thanks to recent advancements in technology, such as VMAT, particle therapy or SBRT, which have gone hand in hand with image guidance techniques and new fractionation paradigms, long-term disease control and improved quality of life have been attained. Despite the successes we have witnessed so far, however, further improved treatment strategies to tailor thoracic cancer care can be envisioned. Areas in particular need of novel insights include the personalization of treatment based on the molecular characteristics of individual tumors as well as on image-based data mining for treatment-related toxicity prediction.
This Special Issue will be focused on the discussion of recent studies and findings showing possible directions for moving the field of radiation therapy for thoracic tumors forward.
We invite the submission of original research papers as well as timely review articles related to these challenges and opportunities. Topics of interest include but are not limited to all recent trends and current issues related to radiation therapy of thoracic tumors.
Dr. Laura Cella
Dr. Giuseppe Palma
Dr. Andrew Hope
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Lung cancer
- Esophageal cancer
- Thymoma and mesothelioma
- Mediastinal Hodgkin's lymphoma
- Molecular-imaging-based dose painting
- Imaging for radiation therapy of thoracic tumors
- Motion challenges in thoracic tumor RT
- Advanced radiation techniques (MRI–Linac, proton therapy, carbon ion)
- Treatment planning optimization
- Tumor control and survival
- Radiation induced toxicity in the thorax
- Radiomics and machine learning